{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:27:23Z","timestamp":1787016443319,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1124\/jpet.112.193284","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T01:52:22Z","timestamp":1337133142000},"page":"497-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Pharmacological Characterization of Abediterol, a Novel Inhaled \u03b22-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical Models"],"prefix":"10.1016","volume":"342","author":[{"given":"M\u00f2nica","family":"Aparici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"G\u00f3mez-Angelats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Otal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Carcasona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Vi\u00f1als","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadeu","family":"Gavald\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"De Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Cortijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Morcillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamish","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Beleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Miralpeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.193284_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.1991.tb12486.x","article-title":"Salmeterol, a novel, long-acting \u03b22-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo","volume":"104","author":"Ball","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.193284_bib2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/jpet.105.098251","article-title":"In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled \u03b22 adrenoceptor agonist with a 24-h duration of action","volume":"317","author":"Battram","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.193284_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12325-010-0017-6","article-title":"The short, the long, and the \u201cultra-long\u201d: why duration of bronchodilator action matters in chronic obstructive pulmonary disease","volume":"27","author":"Beeh","year":"2010","journal-title":"Adv Ther"},{"key":"10.1124\/jpet.112.193284_bib4","first-page":"A5414","article-title":"Efficacy and safety of single doses of inhaled LAS100977 in patients with persistent asthma [abstract]","volume":"181","author":"Beier","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.112.193284_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.110.167007","article-title":"Pharmacological characterization of olodaterol, a novel inhaled \u03b22-adrenoceptor agonist exerting a 24-hour long duration of action in preclinical models","volume":"334","author":"Bouyssou","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.193284_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1124\/jpet.111.179259","article-title":"Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol","volume":"337","author":"Casarosa","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.193284_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MCP.0b013e32833303d2","article-title":"Novel bronchodilators in asthma","volume":"16","author":"Cazzola","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1124\/jpet.112.193284_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0160-5402(89)90023-5","article-title":"Novel and versatile superfusion system. Its use in the evaluation of some spasmogenic and spasmolytic agents using guinea-pig isolated tracheal smooth muscle","volume":"21","author":"Coleman","year":"1989","journal-title":"J Pharmacol Methods"},{"key":"10.1124\/jpet.112.193284_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-2999(91)90617-Y","article-title":"Effects of dantrolene on the responses to methylxanthines in the isolated guinea-pig trachea","volume":"198","author":"Cortijo","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.193284_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00210-003-0818-0","article-title":"Effects of ouabain on human bronchial muscle in vitro","volume":"368","author":"Cortijo","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.112.193284_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0898-6568(96)00068-X","article-title":"Endogenous \u03b23- but not \u03b21-adrenergic receptors are resistant to agonist-mediated regulation in human SK-N-MC neurotumor cells","volume":"8","author":"Curran","year":"1996","journal-title":"Cell Signal"},{"key":"10.1124\/jpet.112.193284_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.drudis.2007.04.003","article-title":"Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies","volume":"12","author":"Fitzgerald","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.112.193284_bib13","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1183\/09031936.06.00112605","article-title":"Beyond the dogma: novel \u03b22-adrenoceptor signalling in the airways","volume":"27","author":"Giembycz","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.112.193284_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1513\/pats.200701-016FM","article-title":"Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators","volume":"4","author":"Hanania","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1124\/jpet.112.193284_bib15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1164\/rccm.2109060","article-title":"\u03b2-Agonist intrinsic efficacy: measurement and clinical significance","volume":"165","author":"Hanania","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.112.193284_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0773.1992.tb00982.x","article-title":"Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro","volume":"71","author":"Jeppsson","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.112.193284_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jaci.2005.11.012","article-title":"Molecular mechanisms of \u03b22-adrenergic receptor function, response, and regulation","volume":"117","author":"Johnson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.112.193284_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1476-5381.1994.tb17047.x","article-title":"The interaction between salmeterol and \u03b22-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro","volume":"113","author":"K\u00e4llstr\u00f6m","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.193284_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01861842","article-title":"Versuchsanorndnung zu untersuchungen an der bronchialmuskulatur","volume":"195","author":"Konzett","year":"1940","journal-title":"Arch Exp Pathol Pharmacol"},{"key":"10.1124\/jpet.112.193284_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1155\/2002\/604092","article-title":"Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study","volume":"9","author":"Kottakis","year":"2002","journal-title":"Can Respir J"},{"key":"10.1124\/jpet.112.193284_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1440-1592.2004.00348.x","article-title":"\u03b22-Adrenergic receptors: structure, regulation and signalling by partial and full agonists","volume":"53","author":"Kurose","year":"2004","journal-title":"Allergol Int"},{"key":"10.1124\/jpet.112.193284_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1398-9995.2007.01555.x","article-title":"Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study","volume":"63","author":"LaForce","year":"2008","journal-title":"Allergy"},{"key":"10.1124\/jpet.112.193284_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.79.1.107","article-title":"Role of \u03b21-receptors and vagal tone in cardiac inotropic and chronotropic responses to a \u03b22-agonist in humans","volume":"79","author":"Levine","year":"1989","journal-title":"Circulation"},{"key":"10.1124\/jpet.112.193284_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tips.2007.04.003","article-title":"Long-acting \u03b22-adrenoceptor agonists: a smart choice for asthma?","volume":"28","author":"Lipworth","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.112.193284_bib25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/thx.2006.062802","article-title":"Developing COPD: a 25 year follow up study of the general population","volume":"61","author":"L\u00f8kke","year":"2006","journal-title":"Thorax"},{"key":"10.1124\/jpet.112.193284_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1398-9995.2004.00526.x","article-title":"The global burden of asthma: executive summary of the GINA Dissemination Committee report","volume":"59","author":"Masoli","year":"2004","journal-title":"Allergy"},{"key":"10.1124\/jpet.112.193284_bib27","first-page":"1647","article-title":"Effects of the new antiallergic drug 11-oxo-11H-pyrido [2,1-b] quinazoline-2-carboxylic acid on bronchial and cutaneous allergic responses to ascaris in dogs","volume":"36","author":"Misawa","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.112.193284_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1183\/09031936.00032806","article-title":"Effect of indacaterol, a novel long-acting \u03b22-agonist, on isolated human bronchi","volume":"29","author":"Naline","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.112.193284_bib29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1183\/09031936.94.07050914","article-title":"Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus","volume":"7","author":"Naline","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.112.193284_bib30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1476-5381.1993.tb13929.x","article-title":"Effects of \u03b2-adrenoceptor agonists in human bronchial smooth muscle","volume":"110","author":"Nials","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.193284_bib31","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1067\/mai.2002.129702","article-title":"\u03b2-Agonists and metabolism","volume":"110","author":"Philipson","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.112.193284_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1742-1241.2003.tb10590.x","article-title":"State of the art in \u03b22-agonist therapy: a safety review of long-acting agents","volume":"57","author":"Rabe","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1124\/jpet.112.193284_bib33","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1345\/aph.1P273","article-title":"FDA's recommendations on the use of long-acting \u03b22 agonists in the management of asthma","volume":"44","author":"Robinson","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.112.193284_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00210-010-0533-6","article-title":"Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled \u03b22-adrenoceptor agonists","volume":"382","author":"Rosethorne","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.112.193284_bib35","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1067\/mai.2002.129966","article-title":"Adverse effects of \u03b2-agonists","volume":"110","author":"Sears","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.112.193284_bib36","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.rmed.2010.06.011","article-title":"24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol","volume":"104","author":"Sugihara","year":"2010","journal-title":"Respir Med"},{"key":"10.1124\/jpet.112.193284_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1465-9921-11-149","article-title":"Long-acting \u03b2-agonists in the management of chronic obstructive pulmonary disease: current and future agents","volume":"11","author":"Tashkin","year":"2010","journal-title":"Respir Res"},{"key":"10.1124\/jpet.112.193284_bib38","first-page":"A5663","article-title":"Single doses of LAS100977, a novel long acting \u03b22-agonist, show high activity and long duration in healthy subjects [abstract]","volume":"181","author":"Timmer","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.112.193284_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-11-135","article-title":"Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium","volume":"11","author":"Vogelmeier","year":"2010","journal-title":"Respir Res"},{"key":"10.1124\/jpet.112.193284_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01728-4","article-title":"\u03b2-Adrenoceptor agonists and asthma\u2013100 years of development","volume":"445","author":"Waldeck","year":"2002","journal-title":"Eur J Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418295X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418295X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.193284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:09:47Z","timestamp":1739966987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418295X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S002235652418295X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.193284","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization of Abediterol, a Novel Inhaled \u03b22-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical Models","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.193284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}